Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia

Background. Multidrug-Resistant Tuberculosis (MDR-TB) is tuberculosis that is resistant to at least both rifampicin and isoniazid. The World Health Organization as reported in 2019 revealed that Ethiopia is among the 20 countries with the highest estimated numbers of incident MDR-TB cases. However,...

Full description

Saved in:
Bibliographic Details
Main Authors: Mikyas Arega Muluneh, Abayneh Birlie Zeru, Behailu Tariku Derseh, Abebaw Molla Kebede
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2021/6696199
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548973346291712
author Mikyas Arega Muluneh
Abayneh Birlie Zeru
Behailu Tariku Derseh
Abebaw Molla Kebede
author_facet Mikyas Arega Muluneh
Abayneh Birlie Zeru
Behailu Tariku Derseh
Abebaw Molla Kebede
author_sort Mikyas Arega Muluneh
collection DOAJ
description Background. Multidrug-Resistant Tuberculosis (MDR-TB) is tuberculosis that is resistant to at least both rifampicin and isoniazid. The World Health Organization as reported in 2019 revealed that Ethiopia is among the 20 countries with the highest estimated numbers of incident MDR-TB cases. However, supporting evidence is limited in the study area after the Ethiopian national strategic plan for tuberculosis prevention and control is started. Objective. To determine survival status and predictors of mortality among multidrug-resistant tuberculosis patients treated in Saint Peter’s Specialized Hospital at Addis Ababa, Ethiopia, 2020. Methods. An institutional retrospective cohort study was conducted using all MDR-TB patients who were enrolled in Saint. Peter’s Specialized Hospital from January 01, 2015, to December 31, 2017. A pretested data extraction form that had 5 items for sociodemographic and 15 items for the measurement of clinical characteristics of 484 MDR-TB patients was used. STATA software version 14.2 was used for data cleaning and analysis. A variable that fitted in the bivariable Cox proportional hazard model at p value <0.25 was used in the final multivariable Cox proportional hazard model, and independent predictors of time to event were determined at a p value of 0.05. Result. A total of 484 patients were followed up for 5,078 person-months. Among the total patients, nearly half, 238 (48.8%), were males. The median age of patients was 30 years (interquartile range (IQR), 24–39), and 56 (11.6%) were aged between 1 and 19 years. During the follow-up period, 315 (65.1%) patients were cured, 125 (25.8%) completed treatment, 24 (5%) died, and 20 (4.1%) were lost to follow-up. The overall cumulative probability survival of the patients at the end of treatment was 94.85% (95% confidence interval (CI): 92.38%–96.53%). The independent predictors of time to death were being anemic (AHR = 3.65; 95% CI: 1.36, 9.79), having clinical complication (AHR = 3; 95% CI: 1.2, 7.5), and being HIV infected (AHR = 5.8; 95% CI: 2.2, 15.7). Conclusions. MDR-TB patients’ survival rate was high in St Peter’s Specialized Hospital. MDR-TB patients with anemia, HIV coinfection, and clinical complications had higher risk of mortality. So, prevention and controlling of anemia, HIV/AIDS, and clinical complications will reduce the mortality of MDR-TB patients.
format Article
id doaj-art-c86651e1aaca467cbd6f66c12433f35a
institution Kabale University
issn 1712-9532
1918-1493
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-c86651e1aaca467cbd6f66c12433f35a2025-02-03T06:12:30ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95321918-14932021-01-01202110.1155/2021/66961996696199Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, EthiopiaMikyas Arega Muluneh0Abayneh Birlie Zeru1Behailu Tariku Derseh2Abebaw Molla Kebede3Department of Midwifery, Institute of Medicine and Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaDepartment of Public Health, Institute of Medicine and Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaDepartment of Public Health, Institute of Medicine and Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaDepartment of Nutrition and Reproductive Health, School of Public Health, Mizan-Tepi University, Tepi, EthiopiaBackground. Multidrug-Resistant Tuberculosis (MDR-TB) is tuberculosis that is resistant to at least both rifampicin and isoniazid. The World Health Organization as reported in 2019 revealed that Ethiopia is among the 20 countries with the highest estimated numbers of incident MDR-TB cases. However, supporting evidence is limited in the study area after the Ethiopian national strategic plan for tuberculosis prevention and control is started. Objective. To determine survival status and predictors of mortality among multidrug-resistant tuberculosis patients treated in Saint Peter’s Specialized Hospital at Addis Ababa, Ethiopia, 2020. Methods. An institutional retrospective cohort study was conducted using all MDR-TB patients who were enrolled in Saint. Peter’s Specialized Hospital from January 01, 2015, to December 31, 2017. A pretested data extraction form that had 5 items for sociodemographic and 15 items for the measurement of clinical characteristics of 484 MDR-TB patients was used. STATA software version 14.2 was used for data cleaning and analysis. A variable that fitted in the bivariable Cox proportional hazard model at p value <0.25 was used in the final multivariable Cox proportional hazard model, and independent predictors of time to event were determined at a p value of 0.05. Result. A total of 484 patients were followed up for 5,078 person-months. Among the total patients, nearly half, 238 (48.8%), were males. The median age of patients was 30 years (interquartile range (IQR), 24–39), and 56 (11.6%) were aged between 1 and 19 years. During the follow-up period, 315 (65.1%) patients were cured, 125 (25.8%) completed treatment, 24 (5%) died, and 20 (4.1%) were lost to follow-up. The overall cumulative probability survival of the patients at the end of treatment was 94.85% (95% confidence interval (CI): 92.38%–96.53%). The independent predictors of time to death were being anemic (AHR = 3.65; 95% CI: 1.36, 9.79), having clinical complication (AHR = 3; 95% CI: 1.2, 7.5), and being HIV infected (AHR = 5.8; 95% CI: 2.2, 15.7). Conclusions. MDR-TB patients’ survival rate was high in St Peter’s Specialized Hospital. MDR-TB patients with anemia, HIV coinfection, and clinical complications had higher risk of mortality. So, prevention and controlling of anemia, HIV/AIDS, and clinical complications will reduce the mortality of MDR-TB patients.http://dx.doi.org/10.1155/2021/6696199
spellingShingle Mikyas Arega Muluneh
Abayneh Birlie Zeru
Behailu Tariku Derseh
Abebaw Molla Kebede
Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia
Canadian Journal of Infectious Diseases and Medical Microbiology
title Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia
title_full Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia
title_fullStr Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia
title_full_unstemmed Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia
title_short Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia
title_sort survival status and predictors of mortality among multidrug resistant tuberculosis patients in saint peter s specialized hospital addis ababa ethiopia
url http://dx.doi.org/10.1155/2021/6696199
work_keys_str_mv AT mikyasaregamuluneh survivalstatusandpredictorsofmortalityamongmultidrugresistanttuberculosispatientsinsaintpetersspecializedhospitaladdisababaethiopia
AT abaynehbirliezeru survivalstatusandpredictorsofmortalityamongmultidrugresistanttuberculosispatientsinsaintpetersspecializedhospitaladdisababaethiopia
AT behailutarikuderseh survivalstatusandpredictorsofmortalityamongmultidrugresistanttuberculosispatientsinsaintpetersspecializedhospitaladdisababaethiopia
AT abebawmollakebede survivalstatusandpredictorsofmortalityamongmultidrugresistanttuberculosispatientsinsaintpetersspecializedhospitaladdisababaethiopia